Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Saturday, 27 April 2024
DEST
LSE
DEST
Summary
|
Chart
|
News
|
History
|
More info..
Recent News
More news...
Destiny Pharma Plc (DEST.L) Sees Awesome Oscillator Trending Upward
21:47 | 13/12/17
The Business Union
Destiny Pharma Plc (DEST.L) market momentum is building as the Awesome Oscillator (AO) is showing an uptrend in the name over the past 5 bars.
more»
Aim-listed Destiny Pharma's shares surge on fresh investment
23:07 | 1/12/17
City A.M.
I am a journalist for City A.M. reporting on the Industrials sector, including o [..] Show more. Follow Courtney. Paracetamol Reportedly Not Effective Drug For Back Pain.
more»
Antibiotic developer Destiny Pharma rockets as Chinese partner invests £3mln ...
22:46 | 1/12/17
Proactive Investors UK
Antibiotic developer Destiny Pharma PLC (LON:DEST) has received a cash injection from its Chinese distributor and partner at a hefty premium to the market price.
more»
Destiny Pharma believes it has the answer to superbug threat
02:41 | 7/10/17
Proactive Investors UK
The urgency and size of the market offers huge potential for any company that can come up with a new way to treat infections safely and Destiny Pharma PLC (LON:DEST) believes it can be the one that does. An AIM listing in September at 157p raised ...
more»
Destiny pulls off IPO to fund infection-prevention trial
01:46 | 6/9/17
FierceBiotech
Destiny Pharma has listed on London's AIM exchange. The IPO gives Destiny £15.3 million ($19.8 million) to assess lead candidate XF-73 in the prevention of postsurgical staphylococcal infections in a phase 2b trial.
more»
Destiny Pharma listed on London Stock Exchange
22:41 | 5/9/17
PharmaTimes
Brighton, UK-based Destiny Pharma has been successfully listed shares on London Stock Exchange with a market capitalisation of £65.4 million, marking the second biotech company to float this year in the UK.
more»
MRSA drug pioneer Destiny Pharma leaps 39% on its first day of trading after ...
08:57 | 5/9/17
This is Money
Destiny is only the second life sciences group to join the London Stock Exchange and is a welcome boost for the British biotech industry, which has struggled to emulate the commercial success of the US.
more»
New float Destiny Pharma's shares race to a 30% debut premium
00:56 | 5/9/17
Proactive Investors UK
Shares in Destiny Pharma plc (LON:DEST), which is chaired by City heavyweight Sir Nigel Rudd, made a cracking stock market debut as the shares raced to a first-day premium of 30%.
more»
FLASH: Destiny Pharma raises £15.3m
18:10 | 4/9/17
Stock Market Wire
DESTINY PHARMA PLC ORD GBP0.01 (DEST) Share Price. 217.50p +217.50p ( +0.00 %) delayed: 18:34PM. Share Price for (DEST) Broker Recommendations for (DEST) Director Deals for (DEST).
more»
EuroBiotech: More Articles of Note
02:48 | 25/8/17
FierceBiotech
Destiny Pharma filed for an IPO on London's AIM. The antimicrobial biotech hired a CEO with IPO experience in April. And has now tapped into that experience to put together an offering to fund its lead candidate up to the start of a pivotal phase 3 ...
more»
1
2
next»
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%